Search
Day One Biopharmaceuticals Inc
DAWNAdd to Watchlist
21.530USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
2.22BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-04-22The current earnings forecast score of Day One Biopharmaceuticals Inc is 6.00, ranking 336 out of 390 in the Biotechnology & Medical Research industry. The average price target is 22.50, with a high of 29.00 and a low of 16.00.
No Data
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Day One Biopharmaceuticals Inc's expected revenue for the next quarter?
Day One Biopharmaceuticals Inc's expected revenue is 55.38M.
What is Day One Biopharmaceuticals Inc's price target?
Analysts forecast that Day One Biopharmaceuticals Inc's price target is USD 22.50, with the highest forecast at USD 29.00 and the lowest forecast at USD 16.00.
How have Day One Biopharmaceuticals IncDAWN's recent earnings per share performed?
The market expectation was USD -0.21, while Day One Biopharmaceuticals IncDAWN's earnings per share (EPS) for the previous quarter was USD -0.19. EPS for the next quarter is expected at USD -0.39.